Ipswich Investment Management Co. Inc. trimmed its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 8.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,862 shares of the company's stock after selling 3,970 shares during the period. Procter & Gamble comprises about 1.7% of Ipswich Investment Management Co. Inc.'s holdings, making the stock its 14th biggest holding. Ipswich Investment Management Co. Inc.'s holdings in Procter & Gamble were worth $7,147,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also modified their holdings of the company. Unique Wealth LLC lifted its stake in Procter & Gamble by 2.9% in the 1st quarter. Unique Wealth LLC now owns 2,141 shares of the company's stock worth $365,000 after acquiring an additional 61 shares in the last quarter. Stableford Capital II LLC lifted its stake in Procter & Gamble by 1.1% in the 1st quarter. Stableford Capital II LLC now owns 5,817 shares of the company's stock worth $993,000 after acquiring an additional 61 shares in the last quarter. Bernard Wealth Management Corp. lifted its stake in Procter & Gamble by 20.2% in the 1st quarter. Bernard Wealth Management Corp. now owns 375 shares of the company's stock worth $64,000 after acquiring an additional 63 shares in the last quarter. B & T Capital Management DBA Alpha Capital Management lifted its stake in Procter & Gamble by 2.3% in the 1st quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company's stock worth $476,000 after acquiring an additional 63 shares in the last quarter. Finally, Private Management Group Inc. lifted its stake in Procter & Gamble by 4.8% in the 1st quarter. Private Management Group Inc. now owns 1,384 shares of the company's stock worth $236,000 after acquiring an additional 64 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on PG. Barclays set a $164.00 price objective on Procter & Gamble and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. Wells Fargo & Company dropped their target price on Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a research report on Thursday. BNP Paribas reaffirmed an "outperform" rating and issued a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. UBS Group set a $180.00 target price on Procter & Gamble and gave the stock a "buy" rating in a research report on Wednesday, July 30th. Finally, Evercore ISI reaffirmed an "in-line" rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $173.78.
Get Our Latest Stock Analysis on PG
Procter & Gamble Stock Performance
Shares of NYSE PG opened at $152.44 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The firm has a market cap of $356.78 billion, a price-to-earnings ratio of 23.42, a P/E/G ratio of 4.01 and a beta of 0.36. The business's 50-day simple moving average is $156.00 and its 200-day simple moving average is $160.60. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm's revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were issued a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. Procter & Gamble's dividend payout ratio is currently 64.82%.
Insider Buying and Selling at Procter & Gamble
In other news, insider Marc S. Pritchard sold 9,849 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the transaction, the insider owned 182,422 shares of the company's stock, valued at approximately $28,689,507.94. This represents a 5.12% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Shailesh Jejurikar sold 13,039 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $2,050,643.53. Following the completion of the sale, the chief operating officer directly owned 28,036 shares in the company, valued at $4,409,221.72. This trade represents a 31.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 120,181 shares of company stock worth $18,918,012 in the last 90 days. Company insiders own 0.20% of the company's stock.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.